Scalable throughput and flexibility for virtually any genome, sequencing method, and scale of project
All Kits & Reagents
Improved Q30 score, support for UMIs, extended shelf life, and support for Illumina DNA PCR-Free Library Prep
All Selection & Planning Tools
Discover novel trait and disease associations with optimized tag SNPs and functional exonic content at an attractive price
All Software & Informatics Products
DRAGEN v3.10 release now available, setting new standards for accuracy and increased genome coverage.
Fast, high-quality, sample-to-data services such as RNA and whole-genome sequencing
All Popular Products
Sequencing and microarray products for diverse applications
All Informatics Education
More About Us
Empower the next generation of scientists and engineers through educational opportunities and resources
More Career Info
All Investor Information
More Business Solutions
All Legal Information
Manage the security and set up networking for your sequencing system
All Support Tools
All Product Support Services
Enable comprehensive genomic profiling with accurate and comprehensive homologous recombination deficiency assessment
All Cancer Research Products
All Microbial Genomics Research
Monitor SARS-CoV-2 variants and other respiratory viruses in the community
All Microbial Genomics Products
All Informatics Products
Mapping genetic diversity to identify where confiscated gorillas come from and boost survival rates
All Agrigenomics Products
Explore the advantages of NGS for analysis of gene expression, gene regulation, and methylation
All Complex Disease Research Products
All Reproductive Health
Comprehensive, IVD, in-lab aneuploidy screening solution for accurate NIPT results in 26 hours
All Reproductive Health Products
Whole-genome sequencing (WGS) for rare disease offers key advantages over other genetic testing methods
All Genetic Health Products
Using a single test assessing hundreds of current and
emerging cancer biomarkers, you can now access a
clinically relevant report with actionable answers.
The MiSeqDx instrument is the first FDA-cleared <i>in vitro</i> diagnostic (IVD) next-generation sequencing (NGS) system.
MiSeqDx applications include FDA-cleared and FDA-approved assays for cystic fibrosis testing, colorectal cancer evaluation, and NGS-based assay development.
FDA-cleared next-generation sequencing panels for detection of causative and clinically relevant variants for cystic fibrosis.